AI
PJP icon

Atria Investments’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Atria Investments’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-47,735
Closed -$3M – 819
2017
Q2 		$3M Buy
+47,735
New +$2.87M 0.18% 106
2016
Q4 		– Sell
-12,009
Closed -$740K – 665
2016
Q3 		$740K Buy
+12,009
New +$786K 0.07% 244

Other funds holding PJP

TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Atria Investments's PJP Position: Q3 2017 in Review

Atria Investments sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2017, closing a stake of 47,735 shares — an estimated $3M sold.

Atria Investments first reported a position in PJP in Q3 2016 and held it in 2 quarters. The position peaked at $3M in Q2 2017. 90 funds tracked by Wall St. Rank hold PJP as of Q3 2017.

  • Atria Investments reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2017 after selling out during the quarter.
  • Atria Investments sold 47,735 Invesco Pharmaceuticals ETF shares in Q3 2017, an estimated $3M.
  • Atria Investments first reported a position in Invesco Pharmaceuticals ETF in Q3 2016 and held it in 2 quarters.
  • Atria Investments's Invesco Pharmaceuticals ETF position peaked at $3M in Q2 2017.
  • 90 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2017.

Based on Atria Investments's 13F filing for Q3 2017, filed 12 Oct 2017.